CL
NPTN

Croft-Leominster’s NEOPHOTONICS CORP NPTN Stock Holding History

Croft-Leominster’s Portfolio NPTN Stock Details NPTN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-22,800
Closed -$180K – 203
2014
Q1 		$180K Hold
22,800
– – 0.03% 173
2013
Q4 		$161K Buy
22,800
+6,800
+43% +$45.3K 0.02% 191
2013
Q3 		$118K Buy
+16,000
New +$125K 0.02% 178

Other funds holding NPTN

AWMDMG
Austin W. Marxe & David M. Greenhouse New York $733M AUM 21.72% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
MCM
Masters Capital Management Atlanta, Georgia $3.03B AUM 57.21% 1-Year Est. Return
ARM
Adirondack Research & Management Guilderland, New York $82.2M AUM 63.78% 1-Year Est. Return
PCM
Penn Capital Management Philadelphia, Pennsylvania $1.29B AUM 53.44% 1-Year Est. Return
SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return
QAM
Quentec Asset Management New York $634M AUM 22.87% 1-Year Est. Return
WPC
White Pine Capital Bloomington, Minnesota $355M AUM 45.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Croft-Leominster's NPTN Position: Q2 2014 in Review

Croft-Leominster sold out of NEOPHOTONICS CORP (NPTN) in Q2 2014, closing a stake of 22,800 shares — an estimated $180K sold.

Croft-Leominster first reported a position in NPTN in Q3 2013 and held it in 3 quarters. The position peaked at $180K in Q1 2014. 60 funds tracked by Wall St. Rank hold NPTN as of Q2 2014.

  • Croft-Leominster reported no remaining NEOPHOTONICS CORP position as of Q2 2014 after selling out during the quarter.
  • Croft-Leominster sold 22,800 NEOPHOTONICS CORP shares in Q2 2014, an estimated $180K.
  • Croft-Leominster first reported a position in NEOPHOTONICS CORP in Q3 2013 and held it in 3 quarters.
  • Croft-Leominster's NEOPHOTONICS CORP position peaked at $180K in Q1 2014.
  • 60 funds tracked by Wall St. Rank held NEOPHOTONICS CORP as of Q2 2014.

Based on Croft-Leominster's 13F filing for Q2 2014, filed 14 Aug 2014.